InvestorsHub Logo
Followers 4
Posts 1198
Boards Moderated 0
Alias Born 10/03/2015

Re: jondoeuk post# 941

Thursday, 03/18/2021 9:42:13 PM

Thursday, March 18, 2021 9:42:13 PM

Post# of 977
TRIL has wasted too much time, even CRIS has developed a combo CA-4948 + ibrutinib to treat Relapsed or Refractory Hematologic Malignancies.
CD-47 space is a big leaking bubble.

https://www.prnewswire.com/news-releases/curis-doses-first-patient-in-phase-1-study-of-ca-4948-in-combination-with-ibrutinib-in-patients-with-relapsed-or-refractory-hematologic-malignancies-301224625.html